Shares of Mallinckrodt (MNK) have dropped more than 10% this afternoon after the New York Post reported that that the Federal Trade Commission was preparing to file charges against the specialty pharmaceutical company. The New York Post's Josh Kosman
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.